In a study involving 276 patients with advanced CRC receiving Irinotecan-based chemotherapy, genotypes of UGT1A1-6 and UGT1A1-28 were determined using PCR amplification and Sanger sequencing. The gene discussed is UGT1A1; the disease is colorectal carcinoma.